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The mammalian small ubiquitin-like modifiers (SUMOs) are actively
involved in regulating differentiation of different cell types. However,
the functional differences between SUMO isoforms and their mech-
anisms of action remain largely unknown. Using the ocular lens as a
model system, we demonstrate that different SUMOs display distinct
functions in regulating differentiation of epithelial cells into fiber
cells. During lens differentiation, SUMO1 and SUMO2/3 displayed
different expression, localization, and targets, suggesting differen-
tial functions. Indeed, overexpression of SUMO2/3, but not SUMO1,
inhibited basic (b) FGF-induced cell differentiation. In contrast,
knockdown of SUMO1, but not SUMO2/3, also inhibited bFGF action.
Mechanistically, specificity protein 1 (Sp1), a major transcription factor
that controls expression of lens-specific genes such as β-crystallins,
was positively regulated by SUMO1 but negatively regulated by
SUMO2. SUMO2 was found to inhibit Sp1 functions through several
mechanisms: sumoylating it at K683 to attenuate DNA binding, and at
K16 to increase its turnover. SUMO2 also interfered with the interac-
tion between Sp1 and the coactivator, p300, and recruited a repressor,
Sp3 to β-crystallin gene promoters, to negatively regulate their ex-
pression. Thus, stable SUMO1, but diminishing SUMO2/3, during lens
development is necessary for normal lens differentiation. In support
of this conclusion, SUMO1 and Sp1 formed complexes during early
and later stages of lens development. In contrast, an interaction be-
tween SUMO2/3 and Sp1 was detected only during the initial lens
vesicle stage. Together, our results establish distinct roles of different
SUMO isoforms and demonstrate for the first time, to our knowledge,
that Sp1 acts as a major transcription factor target for SUMO control
of cell differentiation.
transcription regulation | eye development | crystallin gene expression
The conjugation of small ubiquitin-like modifiers (SUMOs) toprotein substrates (named sumoylation) is a critical post-
translational modification with diverse cellular functions (1).
Three major SUMO isoforms (SUMO1, -2, and -3) were iden-
tified in vertebrates. Although the mature SUMO2 and SUMO3
share a very high level of sequence identity (97%) and cannot be
immunologically discriminated (thus referred to as SUMO2/3),
they significantly differ from SUMO1, with only 45% identity
(2, 3). Recent studies using proteomics revealed that SUMO1
and SUMO2/3 can be targeted to both distinct and overlapping
sets of substrates (4). However, whether SUMO1 and SUMO2/3
have redundant or different functions in vivo is not clear because
inconsistent results have been reported in SUMO1 knockout
mice (5, 6).
SUMO conjugation is executed by three enzymes. The acti-
vating enzyme E1, a heterodimer of SAE1 and SAE2, transfers
SUMO to the single E2-conjugating enzyme Ubc9, which either
sumoylates the substrate alone, or cofunctions with different E3
ligases. Sumoylation is highly dynamic and can be rapidly reverted
by sentrin-specific proteases (SENPs) (7). Functionally, it regu-
lates many cellular processes, including cell differentiation (8–11).
In ocular tissues, sumoylation helps to determine the differentia-
tion of cone versus rod photoreceptors (11). Our recent study
revealed that SUMO1-mediated sumoylation is an indispensable
step toward activation of p32 Pax-6, a master regulator of eye and
brain development (12). Although the effects of sumoylation on
individual targets in regulating cell differentiation and other bi-
ological processes are being unraveled, it remains largely unknown
how SUMO isoforms regulate cell differentiation and whether
SUMO1 and SUMO2/3 display distinct functions.
The vertebrate lens is an attractive model for studying cell
differentiation (13). In this tissue, cell proliferation and differ-
entiation occur throughout life. Differentiation of the vertebrate
lens starts from the lens vesicle (LV) stage. Cells in the anterior
of the LV retain epithelial morphology and proliferative capacity
whereas the posterior cells elongate and differentiate into pri-
mary lens fiber cells (LFCs). The lens constantly grows throughout
life via continued proliferation and differentiation of lens epi-
thelial cells (LECs) in the germinal zone into secondary LFCs.
Formation of both primary and secondary LFCs is characterized
by elongated cell shape, accumulation of differentiation-specific
proteins such as β-crystallins, and loss of subcellular organelles.
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In vitro and in vivo, lens differentiation can be triggered by
extracellular growth factors, such as basic fibroblast growth factor
(bFGF) (14). When cultured in high concentration of bFGF
(50∼100 ng/mL), LECs elongate, migrate, and become multi-
layered to form LFCs (13, 14). Furthermore, accumulation of
differentiation-specific β-crystallin is induced upon prolonged
culture (14). However, loss of nuclei was not detected in this
condition (14), implying that the in vitro model mimics early stages
of in vivo fiber differentiation.
Using this system, we explored the functions of SUMO1 and
SUMO2/3 in cell differentiation. Our results reveal that SUMO1
and SUMO2/3 differ significantly in abundance, localization, and
substrate targets. Although SUMO1 promotes cell differentia-
tion, SUMO2/3 inhibits this process. Such distinct functional
differences are in part mediated through transcription factor
Sp1. Although SUMO1 directly sumoylates Sp1 to positively
regulate β-crystallin genes, SUMO2 inhibits Sp1 function by at-
tenuating its DNA binding activity, decreasing its protein stability,
and suppressing its interactions with the coactivator p300. To-
gether, our results demonstrate distinct functional roles and
mechanisms of action for SUMO1 and SUMO2/3 in regulating
lens cell differentiation.
Results
SUMO1 and SUMO2/3 Display Significant Differences in Expression
and Cellular Localization During Mouse-Lens Development. To ex-
plore the possible roles of SUMO1 and SUMO2/3 in lens-cell
differentiation, we examined their expression and localization
patterns from embryonic day 9.5 (ED9.5) to day 3 lens using
immunohistochemistry (IHC). As shown in Fig. S1, strong signals
of SUMO1 and SUMO2/3 were ubiquitously detected in all LV
cells (Fig. S1) (ED11.5), and a similar pattern of SUMO1 and
SUMO2/3 expression was detected at ED13.5 (Fig. S1). At
ED16.5, when active fiber differentiation takes place, homoge-
nous SUMO1 distribution was detected in nuclei of LECs at the
anterior portion of the lens (Fig. 1 A, b and b2). At the transition
zone, SUMO1 labeling started to move toward the nuclear pe-
riphery (NP) (Fig. 1 A, b and b1). In elongating LFCs moving out
of the transition zone, SUMO1 labeling was primarily detected
at the NP (Fig. 1 A, b and b1). For LFCs localized at deeper
layers undergoing terminal differentiation, the NP localization of
SUMO1 was more prominent (Fig. 1 A, b and b2). By contrast,
SUMO2/3 staining was prominently represented by intensity
change during lens differentiation. Strong SUMO2/3 labeling
was detected in LEC nuclei, with a decreased signal in elongating
primary LFCs (Fig. 1 A, d and d1), and eventually the signal
disappeared in terminally differentiated LFCs (Fig. 1 A, d and
d2). Similar patterns were observed in the day 3 lens (Fig. S1). In
the adult lens, SUMO1 labeling was mainly seen in LECs, with
a detectable level in the differentiating LFCs of the transition
zone (Fig. S1). In contrast, the SUMO2/3 signal was much lower
in the LECs and became hardly detectable in LFCs of the
transition zone (Fig. S1).
SUMO1 and SUMO2/3 Are Conjugated to Different Targets During
Mouse-Lens Differentiation. The different distributions of SUMO1
and SUMO2/3 in differentiating LFCs suggest that they may
be conjugated to different targets. Indeed, Western-blot analysis
(WB) suggested that SUMO1 and SUMO2/3 modified distinct
targets (Fig. 1B). Neither SUMO1 nor SUMO2/3 was detected
in their free forms (in Fig. 1B, no bands with 11 kDa were
observed), indicating that the observed IHC signals (Fig. 1A and
Fig. S1) represent sumoylated proteins. Interestingly, an in-
creased SUMO1 modification of several lower molecular weight
proteins was observed in adult lens (Fig.1B, red arrow heads).
The older lens has a higher content of secondary LFCs than
embryonic or younger lenses, and WB conducted on different
lens compartments showed that the newly SUMO1-modified
species indeed came from the secondary LFCs (the Co-LF lane
of Fig. 1C, Left). A comparison of the WB result (Fig. 1B, Left)
with the Coomassie blue staining (Fig. S2A) or silver staining
(Fig. S2B) of the same samples (indicated by black or white
arrow heads, respectively) suggested that the increased SUMO1
signals appeared to come from enhanced sumoylation instead of
altered expression of SUMO1 substrates. By contrast, SUMO2/3
modifications were limited to the same substrates but showed
a significant reduction in density as lens ages (Fig. 1B, Right).
Furthermore, SUMO2/3 conjugates were detected only in LECs
of adult mice (Fig. 1C, Right and Fig. S1). Reduced SUMO2/3
conjugation is likely derived from decreased SUMO2/3 expres-
sion (Fig. S2D) rather than enhanced desumoylation because no
free SUMO2/3 were detected (Fig. 1C, Left). In addition, dot
blot-based WB (Fig. S2 C and D) showed that SUMO1 is more
abundant than SUMO2 and is thus the major SUMO isoform
in the lens. Decreased SUMO2/3 expression is necessary for
normal lens differentiation to occur (see the section below).
SUMO1 Promotes, Whereas SUMO2/3 Inhibits, Lens-Fiber Differentiation.
The differential expression profiles, cellular localization, and con-
jugation patterns of SUMO isoforms imply that SUMO1 and
SUMO2/3 may play distinct roles in lens differentiation. To ex-
plore this possibility, mouse lens epithelial cells (MLECs) were
subjected to bFGF treatment to induce fiber differentiation (Fig.
S3). Although bFGF enhanced SUMO1 conjugation, it modestly
decreased SUMO2 modification (FGF lanes of Fig. 1C). To
analyze the functions of SUMO isoforms in bFGF-induced LFC
Fig. 1. SUMO1 and SUMO2/3 are differentially expressed and conjugated
during lens differentiation. (A) Cryosections of mouse eye at embryonic day
(ED) 16.5 were processed for IHC and observed under a confocal microscope.
Lens epithelial (LE) cells and lens fiber (LF) cells are indicated by arrow and
arrow head, respectively. (a and c) Overlapping of SUMO1 or SUMO2 (green)
image with nuclei (DAPI staining, blue). (b and d) IHC staining of SUMO1 or
SUMO2. (Magnification: a–d, 100×.) (b1, b2, d1, and d2) Magnifications of
boxed areas in b and d, respectively. (B) WB showing conjugation of SUMO1
(Left) and SUMO2/3 (Right) in mouse lenses of indicated ages. NB, newborn;
7D, 7 d; 2M, 2 mo. The newly sumoylated protein species in the adult lens are
indicated by red arrow head. (C) WB showing SUMO1 (Left) and SUMO2
(Right) in adult mouse lenses and bFGF-induced αTN4-1 cells. Protein species
with enhanced SUMO1 modification or decreased SUMO2 modification un-
der bFGF treatment were indicated by red asterisk or blue asterisk, re-
spectively. Those also modified by SUMO1 or SUMO2 in vivo were labeled
with red or blue arrow head, respectively.








differentiation, we stably expressed SUMO1, SUMO2, or SUMO3
in MLECs (αTN4-1 line); stable clones were established and
expression of SUMO1/2/3 was confirmed (Fig. S4B). The stable
clones were treated with or without 100 ng/mL bFGF to induce
fiber differentiation. After bFGF treatment, both vector GFP- and
SUMO1-transfected αTN4-1 cells demonstrated multilayered LFC
morphology with lentoid bodies (Fig. 2 A, a′–c′ and d′–f′). In
contrast, SUMO2- and SUMO3-transfected αTN4-1 cells still
remained as a monolayer after 15-d bFGF treatment (Fig. 2 A, g′–i′
and j′–l′). Consistent with these morphological differences, bFGF-
induced β-crystallin was suppressed in both SUMO2- and SUMO3-
transfected αTN4-1 cells (Fig. 2B). To confirm that SUMO1 is
necessary for lens differentiation, SUMO1 was stably silenced in
αTN4-1 cells (Fig. S4C). As a result, bFGF-induced fiber differ-
entiation was significantly inhibited by SUMO1 knockdown (Fig. 2
C and D) but not by SUMO2 or SUMO2/3 knockdown (Fig. 2 C
and D). The observed suppression of differentiation correlated
with enhanced cell proliferation of SUMO1-silenced cells (Fig. 2E).
Together, our results reveal that SUMO1 promotes, but SUMO2
and -3 inhibit bFGF-induced LFC differentiation.
SUMO1 and SUMO2/3 Differentially Regulate Sp1 Activity. To explore
the possible molecular mechanisms mediating the regulation of
lens differentiation by SUMO1 and SUMO2/3, we explored their
targets. Knowing that, during lens differentiation, β-crystallins
are greatly induced, we examined their core promoters and
found that the most common consensus cis-element is the site
bound by the Sp1/Sp3 transcription factors (Fig. S5 A–C) (15).
Electrophoretic mobility-shift assay (EMSA) confirmed that Sp1
and Sp3 directly bound to the core promoter regions of human
βB1-, βB2-, and βB3-crystallins (Fig. S5 D–F). Furthermore, Sp1
significantly transactivated the β-crystallin gene promoter-driven
luciferase reporter constructs (Fig. S5 G, a–c) and endogenous
β-crystallin expression (Fig. S5 G, d–f). This Sp1-mediated acti-
vation disappeared when the Sp1 binding sites were mutated in
the reporter-gene constructs (Fig. S5 G, a–c).
Next, we explored whether SUMO1 and SUMO2/3 can
modulate Sp1 activity. Coexpression of Sp1 with SUMO1 en-
hanced luciferase reporter gene activity (Fig S5 G, a–c) (P < 0.05
in all cases) and endogenous β-crystallin expression (Fig. S5 G,
d–f). In contrast, coexpression of Sp1 with SUMO2 significantly
down-regulated reporter-gene activity and endogenous β-crys-
tallin expression (Fig. S5G). As control, expression of SUMO1
or SUMO2 alone did not yield obvious changes in luciferase
activities and endogenous β-crystallin expression (Fig. S5G).
Thus, SUMO1 and SUMO2 differentially regulate Sp1 tran-
scriptional activity in the lens system.
Conjugation of Sp1 by SUMO1 and SUMO2 at K683 Has Differential
Effects on DNA Binding Activity. To understand how SUMO1 and
SUMO2 differentially affect Sp1 activity, we examined their
effects on Sp1 DNA binding. Previous studies have revealed that
Sp1 has a conserved SUMO acceptor site at K16 (16). A careful
examination of the C-terminal portion of the Sp1 primary struc-
ture identified another putative sumoylation site at K683 (Fig.
S6 A, a). In vitro-translated Sp1 DNA binding domain (DBD)
containing this site was subjected to sumoylation by SUMO1 or
SUMO2. Sp1 K683 was preferentially sumoylated by SUMO2
(Fig. S6 A, b), and SUMO2-conjugated Sp1 DBD displayed
weaker binding to the βB1-crystallin gene promoter than SUMO1-
conjugated Sp1 DBD did (compare lane 6 with lane 8 in Fig. S6
B, b). When K683 was mutated to arginine (R), the difference
in the DNA binding patterns by Sp1 DBD after SUMO1 or
SUMO2 conjugation disappeared (compared lane 12 with lane 14
in Fig. S6 B, b). Thus, differential conjugation of Sp1 by SUMO1
and SUMO2 at K683 led to differential effects on Sp1 DNA
binding activity.
SUMO1 and SUMO2 Exert Opposing Effects on Sp1 Stability.We next
examined Sp1 stability in response to conjugation with SUMO1
or SUMO2. Sp1 protein expression was examined in nuclear
(NE) and cytoplasmic fraction (Cyto) extracted from mock
or bFGF-induced cells transfected with vector, SUMO1, or
SUMO2 (Fig. 3A). bFGF treatment increased nuclear Sp1 level
in both GFP- and SUMO1-transfected αTN4-1 cells, but Sp1
expression was reduced in SUMO2-transfected αTN4-1 cells
either before or after bFGF treatment, compared with the
vector-transfected cells under the same conditions (Fig. 3 A, a).
Consistently, cotransfection with SUMO2 into human lens epi-
thelial (HLE) cells also decreased Sp1 expression (Fig. 3 A, b).
This SUMO2-mediated Sp1 decrease is not derived from de-
creased mRNA level (Fig. 3 A, c), but from the decreased pro-
tein stability as revealed with cyclohexamide treatment (to block
protein synthesis, Fig. 3 A, d). In contrast, cotransfection with
SUMO1 significantly increased the Sp1 protein expression (Fig.
3 A, d). This result is interesting because a previous study with
cancer cells showed that modification by SUMO1 at K16 de-
creased Sp1 stability (16). To confirm the above results, we
mutated K16 into R in Sp1 and cotransfected Sp1-K16R with
SUMO1 or SUMO2. Mutation of K16 did not affect SUMO1-
induced Sp1 increase but suppressed SUMO2-dependent Sp1
degradation (Fig. 3 A, d). Thus, SUMO1-enhanced Sp1 expression
may be derived from enhanced mRNA translation (17) but is not
due to direct modification of Sp1. Taken together, SUMO1 and
SUMO2 have differential effects on Sp1 expression.
Fig. 2. Contrasting effects of SUMO1 and SUMO2/3 on bFGF-induced fiber
differentiation. (A) αTN4-1 cells stably expressing GFP, GFP-SUMO1, GFP-
SUMO2, or GFP-SUMO3 were left untreated (a–l) or treated with bFGF for 15 d
(a′–l′). Cell morphology was observed under a phase contrast microscope
(PH) or under a fluorescence microscope to detect GFP or nuclei (DAPI).
(Magnification: 50×.) (B) WB to show β-crystallin in four stable cell lines
without (Mock; 15 d) or with (FGF; 15 d) bFGF induction. (C ) Established
mock (Mock), SUMO1 knockdown (SUMO1 sh), SUMO2 knockdown
(SUMO2 sh), or SUMO2/3 knockdown (SUMO2/3 sh) αTN4-1 cells were
treated with bFGF to induce fiber differentiation for 8 d. (Magnification:
50×.) (D). WB to show β-crystallin expression in Mock, SUMO1 sh, SUMO2
sh, and SUMO2/3 sh cells during bFGF-induced fiber differentiation. (E )
MTT assay to evaluate the cell proliferation in different cells indicated.
Experiments were done in triplicate and represent mean values ± SD.
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SUMO1 Promotes, but SUMO2/3 Suppresses, the Interactions Between
Sp1 and p300. Besides the effects on DNA binding and stability,
SUMO2 may suppress the transcriptional activity of Sp1 by
recruiting a repressor or preventing coactivator binding to
β-crystallin promoters (18). Sp3 is known to act as a repressor of
the Sp family (19), and our results showed that it could directly
bind to the β-crystallin promoters (Fig. S5 D–F) and repress
their activation by Sp1 (Fig. S6 C, a–c). Histone acetyltransferase
p300 is an important coactivator for Sp1 during cell differ-
entiation (18). Quantitative chromatin immunoprecipitation
(qChIP) showed that, although the Sp1 enrichment was not
altered in each cell line, overexpression of SUMO2 led to a sig-
nificantly higher Sp3 occupancy at β-crystallin promoters, and
p300 enrichment was greatly suppressed (Fig. 3B). In contrast,
higher p300 occupancy was found in SUMO1-αTN4 cells. We
hypothesized that SUMO2 expression may interfere with the
interaction between Sp1 and p300; thus, a coimmunoprecipi-
tation (Co-IP)-linked WB was conducted. Indeed, cotransfec-
tion with SUMO2 led to decreased interaction between Sp1 and
p300 (Fig. 3 C, a). Additionally, the endogenous Sp1 and p300
interaction was further investigated under bFGF treatment.
Without the differentiation signal, interaction between en-
dogenous Sp1 and p300 was detectable only in SUMO1-
transfected cells. In the presence of bFGF, such interaction
was induced in GFP-transfected cells and dramatically increased
in SUMO1-transfected cells but was undetectable in the SUMO2-
transfected αTN4-1 cells (Fig. 3 C, b). To further confirm the
interference of SUMO2 conjugation with the interaction between
p300 and Sp1, an in vitro direct binding assay was conducted. As
shown in Fig. S6D, sumoylation of Sp1 with SUMO2 inhibited
its interaction with p300, but sumoylation with SUMO1 en-
hanced the interaction.
Taken together, SUMO2 negatively regulated Sp1 activity by
attenuating DNA binding, decreasing Sp1 protein stability, and in-
terfering with the interaction between Sp1 and its coactivator p300.
To confirm the functional importance of sumoylation at K16
and K683 of Sp1 by SUMO1 and SUMO2/3, we conducted
rescue study under Sp1 knockdown background with a shRNA
plasmid targeting at the 3′-non translation region. Transfection
of K16R mutant Sp1 into the Sp1 knockdown cells could not
restore bFGF-induced differentiation (Fig. S7). In contrast, ex-
pression of the K683R mutant Sp1 rescued bFGF-induced dif-
ferentiation (Fig. S7). Together, these results further confirm the
importance of Sp1 sumoylation by SUMO1 and SUMO2 in
regulating lens differentiation.
SUMO1 and SUMO2/3 Differentially Sumoylate Sp1 at Different
Developmental Stages of Mouse Lens. To demonstrate that Sp1 is
actually subjected to SUMO modulation in vivo, we first ex-
amined the possible colocalization of Sp1 and SUMO1, or Sp1
and SUMO2/3, in mouse embryonic lens. As shown in Fig. 4A, Sp1
and SUMO1 or SUMO2/3 can be colocalized in the lens vesicle as
early as ED11.5. Notably, the colocalization of Sp1 and SUMO1
is relatively homogenous in the anterior LECs and posterior
differentiating cells of the lens vesicle (Fig. 4A, Upper, arrow). In
contrast, colocalization of Sp1 and SUMO2/3 is mainly seen in
the anterior epithelium (arrow) but greatly reduced in the pos-
terior cells undergoing differentiation into primary LFCs (Fig.
4A, Lower, arrow head). To confirm differential interactions
between Sp1 and different SUMOs, Co-IP experiments were
conducted. As shown in Fig. 4B, although Sp1 and SUMO1
formed a complex at both ED11.5 and newborn (NB) stages,
a complex between Sp1 and SUMO2/3 was detected only at
ED11.5 but not in the NB stage (Fig. 4 B, a), which mainly
comprise differentiating lens fiber (LF) cells. Similar results
were obtained when SUMO antibodies were used for the im-
munoprecipitation and when Sp1 antibody was used for im-
munoblotting (Fig. 4 B, b). To further confirm the differential
regulation of the β-crystallin gene promoters by SUMO1 and
SUMO2/3, we conducted qChIP assays. As shown in Fig. 4C,
a sequential qChIP using anti-SUMO1 first and then anti-Sp1
antibodies revealed that SUMO1 and Sp1 were found bound to
the β-crystallin gene promoters in the regions where the Sp1
binding sites were present. In contrast, binding by SUMO2/3 or
SUMO2/3-conjugated Sp1 to these promoters in NB lens was at
background levels because the sequential qChIP assays with
Fig. 3. SUMO1 and SUMO2 differentially regulate Sp1 stability and inter-
actions with other factors. (A) SUMO2 overexpression decreased Sp1 stabil-
ity. (a) WB to show Sp1 level in nucleus and cytoplasm of the indicated cell
lines without or with bFGF treatment. (b) Myc-tagged Sp1 (Myc-Tag-Sp1)
was cotransfected with equal amount of HA-tagged SUMO1 or -SUMO2 into
HLE cells. (c) mRNA level of Sp1 was examined by qPCR at the indicated
transfections. (d) Cycloheximide (100 μg/mL) treatment to assess the effect
of SUMO1 or SUMO2 on the steady level of Sp1 wild type (WT) or K16R
mutant (K16R) in HLE cells. The numbers below the β-Actin lanes are the
relative levels of Sp1 expression under different conditions. (B). qChIP
showing that SUMO2 overexpression enhances Sp3 but suppresses p300
binding into βB1, βB2, and βB3 promoters. (C) SUMO2 overexpression
inhibits interactions between Sp1 and p300. (a) Myc-Sp1 was cotransfected
with SUMO1 or SUOM2 and then precipitated by Myc-tagged magnetic bead
conjugate. Interactions with p300 under indicated transfections were
detected by WB using anti-p300 and anti-IgG antibodies (an equal amount
of normal IgG was also added into input samples for loading comparison).
(b) SUMO2 overexpression inhibits interactions between Sp1 and p300 dur-
ing bFGF induction. GFP, SUMO1, and SUMO2-αTN4-1 cells were untreated
(Mock) or treated with 100 ng/mL bFGF to induce fiber differentiation. A
total of 5 mg of proteins were used in each IP. The resulting precipitates
were separated by 6% SDS/PAGE gel and analyzed by WB.








anti-SUMO2 and anti-Sp1 yielded similar results with anti-SUMO2
alone. Taken together, SUMO1 and SUMO2/3 differentially
control lens differentiation, and the transcription factor Sp1
acts as a key mediator during lens morphogenesis.
Discussion
Mechanisms for SUMO-Mediated Control of Cell Differentiation.
Regulation of cell differentiation by SUMOs has been ex-
plored in numerous cases. In the retina, Pias3-mediated
sumoylation of the transcription factor Nr2e3 converts it into
a potent repressor of cone-specific gene expression, thus acting
as a key mechanism for rod specification (11). Sumoylation dy-
namics also plays a key role in the reprogramming and differ-
entiation of the human endometrial stromal cells (HESCs) (8).
Global SUMO1 deconjugation occurred during HESC dif-
ferentiation, correlating with altered E3 ligase and protease
expressions (8). In contrast, during calcium-induced keratinocyte
differentiation, overall enhanced SUMO1 modifications were
accompanied by up-regulation of sumoylation system compo-
nents (9). Although it is now well-established that sumoylation
plays important roles in regulating cell differentiation (8–12),
little is known regarding the impact of the individual SUMO
paralogues. An early study has shown that haploinsufficiency of
SUMO1 led to cleft lip and palate in embryonic mice (5), sug-
gesting that SUMO2/3 do not substitute for SUMO1. However,
more recent studies showed that SUMO1+/− and SUMO1−/−
mice seemed to develop normally, suggesting that different
SUMO isoforms may have redundant functions in vivo (6). At
this stage, we do not know whether depletion of SUMO1 or
SUMO2/3 will have prominent effects on lens development.
Nevertheless, in the present study, several lines of evidence
suggest that SUMO1 and SUMO2/3 have different functions.
First, SUMO1 and SUMO2/3 showed clear difference in ex-
pression, cellular localization, and conjugation substrates. In
differentiating LFCs, the SUMO1 signal was mainly detected
at the nuclear periphery, and this nuclear-rim localization be-
came prominent in LFCs undergoing terminal differentiation
(Fig. 1A). By contrast, SUMO2/3 were detected only in un-
differentiated LECs and a small portion of LFCs in the transition
zone (Fig. 1 A and C). This confined localization of SUMO2/3
implies that SUMO2/3 either are not required for fiber dif-
ferentiation or, more likely, have inhibitory functions on lens
differentiation (see more discussion in the later part of this
paragraph). Secondly, in a well established bFGF-induced LFC
differentiation model (13, 14) (Fig. S3), globally enhanced
SUMO1 conjugations were observed during this process, but
SUMO2/3 modifications were nonresponsive to bFGF (Fig.
1C). Overexpression of exogenous SUMO1 and SUMO2/3 in
MLECs resulted in different phenotypes. Similar to vector-
transfected cells, overexpression of SUMO1 allows bFGF in-
duction of lens differentiation (Fig. 2). In contrast, when
SUMO2 and SUMO3 were overexpressed in MLECs, bFGF-
induced fiber differentiation was markedly suppressed (Fig. 2).
On the other hand, silencing of SUMO1 significantly inhibited
bFGF-induced fiber differentiation and enhanced cell pro-
liferation (Fig. 2), implying that expression of SUMO1 in
differentiating fiber cells at the transition zone is necessary for
cell-cycle exit and initiation of the fiber-differentiation program.
In comparison, knockdown of SUMO2 or SUMO2/3 had little
effect on bFGF-induced differentiation (Fig. 2). Thirdly,
SUMO1 and SUMO2/3 differentially modulate Sp1 activity.
Although SUMO1 enhances Sp1 activity, SUMO2/3 sup-
presses its activity, supporting the notion that down-regulation of
SUMO2/3 expression is necessary for lens differentiation. In-
deed, this result is exactly what we have observed in mouse lens
(Fig. 1B). Thus, our results favor that SUMO1 and SUMO2/3
cannot substitute each other during lens development as
observed in other tissues (5). The observed normal development
with SUMO1 deletion reported in a more recent study (6) is likely
derived from the situation that some mice with abnormal de-
velopment under SUMO1 deficiency die at embryonic stage. To-
gether, our present study reveals that SUMO1 and SUMO2/3
display distinct functions in controlling cell differentiation. Mecha-
nistically, such functional difference is derived from their differen-
tial modulation of key transcription factors (see the section below).
SUMO1 and SUMO2 Differentially Modulate Sp1 to Mediate Cell
Differentiation. To explore the molecular mechanisms by which
SUMO1 and SUMO2 differentially regulate lens differentiation,
Fig. 4. SUMO1 and SUMO2/3 modulates Sp1 in mouse lens. (A, Upper)
Colocalization (yellow) between Sp1 (red) and SUMO1 (green) was analyzed
by IHC in ED11.5 mouse lens. (Lower) Colocalization (yellow) between Sp1
(red) and SUMO2/3 (green) was analyzed by IHC in ED11.5 mouse embryonic
lens. The overlapping coefficiency for SUMO1 and Sp1 is 0.953 and is 0.921 for
SUMO2/3 and Sp1 using the thresholds method (SI Methods). (Magnification:
50×.) (B) Co-IP to show modifications of Sp1 by SUMO1 or SUMO2/3. Total
proteins were extracted from ED11.5 eye or NB mouse lens, immunopreci-
pitated by anti-Sp1 (a), anti-SUMO1, or anti-SUMO2/3 antibodies (b). The
precipitated samples were immune-blotted with anti-SUMO1 (a, Upper) or
anti-SUMO2/3 antibodies (a, Lower), or anti-Sp1 antibody (b). Note that both
SUMO1 and SUMO2/3 were detected in proteins precipitated by anti-Sp1
antibody at ED11.5, but only SUMO1 detected at NB lens (a). Similarly, at
ED11.5, SUMO-Sp1 signal was found in anti-SUMO1-and SUMO2/3-pelleted
samples but not in control IgG (b, Upper). In NB lens, however, SUMO-Sp1
signal was found only in anti-SUMO1–pelleted sample but not in control IgG
or anti-SUMO2/3–pelleted samples (b, Lower). (C) SUMO1 but not SUMO2/3
occupies βB1, βB2, and βB3 promoters as analyzed by qChIP. (D) Schematic
diagram to show that SUMO1 and SUMO2 differentially regulate lens dif-
ferentiation through Sp1. +, positive regulation; −, negative regulation.
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we explored their conjugated targets. We found here that the
major lens differentiation marker genes coding for β-crystallins
were expressed upon bFGF-induced differentiation in vitro or in
vivo (Fig. 2). Moreover, we demonstrated that all of the β-crys-
tallin gene promoters have well-conserved Sp1/Sp3 binding sites
(Fig. S5 A–C). Sp1 is a universal transcription factor that has
been shown to control expression of many genes from viral to
cellular (15, 20). In the present study, the results of EMSA
experiments demonstrated that Sp1 strongly binds to β-crystallin
gene promoters (Fig. S5 D–F) and positively regulates their ex-
pression (Fig. S5G). Moreover, coexpression of the exogenous
SUMO1 and SUMO2 with Sp1 differentially modulates these
genes. Although SUMO1 enhanced β-crystallin gene expression,
SUMO2 significantly inhibited these promoters (Fig. S5G).
Furthermore, the Sp1 knockdown cells can only be rescued by
a K683R (a SUMO2-favored sumoylation site) mutant but not by
K16R mutant (Fig. S7).
At the molecular level, Sp1 conjugation by SUMO1 and
SUMO2 has different outcomes. We found that Sp1 has a novel
sumoylation site at K683 in the DNA binding domain, which
shows preferred conjugation by SUMO2 (Fig. S6 A, b). SUMO2
conjugation at this site attenuates Sp1 DNA binding activity (Fig.
S6B). Although both SUMO1 and SUMO2 can be conjugated to
Sp1 at K16, conjugation of SUMO2 to this site significantly
decreases Sp1 stability (Fig. 3A). In contrast, SUMO1 conjuga-
tion to Sp1 has no direct effect on protein stability (Fig. 3A). This
result differs from a previous study with cancer cells where
SUMO1 modification led to Sp1 degradation (16). Such an in-
consistence may be due to cell-specific effects. Finally, SUMO1
and SUMO2 differentially direct Sp1 interactions with repressors
and coactivators. Previous studies showed that the interaction
with p300 enhanced Sp1 DNA binding activity (18). We found
that coexpression of Sp1 with SUMO1 prevents its interactions
with the sibling repressor, Sp3, but enhanced its interaction with
the coactivator, p300 (Fig. 3C and Fig. S6D). In contrast, coex-
pression of Sp1 with SUMO2 led to the opposite effects:
SUMO2 recruits Sp3 to the β-crystallin gene promoters (Fig. 3B)
but prevents the association between Sp1 with p300 (Fig. 3C and
Fig. S6D).
Because the outcomes of Sp1 conjugation by SUMO1 and
SUMO2 are so different, progression of lens differentiation
would require one of two conditions: either the lens must have
a fine mechanism to ensure specific Sp1 sumoylation by SUMO1
vs. SUMO2/3 at specific developmental stages if they are
expressed at similar levels, or, more simply, they display differ-
ential expression patterns such that SUMO1 is present when it is
needed and SUMO2 disappears when it is not required. Our
results demonstrate that the lens apparently adopts the latter
strategy (Fig. 1 and Fig. S1). Although SUMO1 is strongly
expressed and conjugated during the embryonic stage and is
maintained at a certain level in the postnatal stages (Fig. 1 and
Fig. S1), expression of SUMO2/3 is gradually decreased and is
present only in the epithelial cells of the adult lens (Fig. 1C and
Fig. S1). In this way, the presence of SUMO1 allows positive
regulation of lens differentiation (Fig. 2 A and B). In contrast,
the absence of SUMO2/3 in lens-fiber cells would pose no in-
hibition on lens differentiation. Moreover, the confinement of
SUMO2/3 in LECs also ensured that LECs remain in the epi-
thelial status. These observations would be consistent with
results from both in vitro and in vivo studies. In the in vitro
bFGF induction of lens differentiation, although SUMO1-con-
jugated proteins are gradually increased from day 0 to day 15
(Fig. 1B), the SUMO2/3-conjugated substrates are gradually
decreasing during the same period. During normal lens de-
velopment, Sp1 conjugation by SUMO1 was detected by ho-
mogenous localization in lens vesicle (ED11.5) (Fig. 4A) and by
Co-IP in both ED11.5 and NB lenses (Fig. 4B). In contrast, Sp1
conjugation by SUMO2/3 was detected only by colocalization in
the anterior epithelial cells of the lens vesicle (ED11.5) and was
further confirmed by Co-IP (Fig. 4 A and B). At the NB lens, Co-IP
confirmed that Sp1 was not modified by SUMO2/3 (Fig. 4B). Thus,
our study here provides an important conclusion: down-regulation
of SUMO2/3 as lens differentiation proceeds is necessary for
normal lens to complete differentiation.
In summary, our present study has clearly demonstrated that
SUMO1 and SUMO2/3 have distinct functions in regulating
lens-cell differentiation, which is derived from their differential
effects on Sp1 and possibly other transcription factors (Fig. 4D).
Methods
Mice used in this study were handled in compliance with the Guide for the
Care and Use of Laboratory Animals. Embryonic and adult mice were
obtained from the University of Nebraska Medical Center breeding facility.
Other analytical methods used in this study are detailed in SI Methods.
Oligo primers used in the generation of various plasmids, qRT-PCR, and
qChIP are listed in Tables S1 and S2.
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